Home/Filings/4/0001104659-24-001165
4//SEC Filing

Enright William 4

Accession 0001104659-24-001165

CIK 0001828185other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 8:54 AM ET

Size

5.9 KB

Accession

0001104659-24-001165

Insider Transaction Report

Form 4
Period: 2024-01-02
Enright William
DirectorChief Executive Officer
Transactions
  • Award

    Share Option (Right to Buy)

    2024-01-02+443,981443,981 total
    Exercise: $3.70Exp: 2034-01-02Ordinary Shares (443,981 underlying)
Footnotes (2)
  • [F1]The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 2, 2025.
  • [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Issuer

Barinthus Biotherapeutics plc.

CIK 0001828185

Entity typeother

Related Parties

1
  • filerCIK 0001705564

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 8:54 AM ET
Size
5.9 KB